Pfizer Ltd. (India)

Bayer has asked investors for patience as the conglomerate works its way through various challenges across its pharmaceuticals, crop science and consumer health businesses, and in 2024 pharma showed t

Pharma firms operating in India may need to make certain key modifications to their current data privacy programs, including adapting newer controls, to align with the country’s digital personal data

Pharma firms operating in India may need to make certain key modifications to their current data privacy programs, including adapting newer controls, to align with the country’s digital personal data

AI is rescripting norms around customer engagement, personalization, and efficiency, opening up a range of opportunities for pharma in the marketing arena, albeit with appropriate guardrails. There’s